Head and Neck Cancers - Salivary Gland trials recruiting in Connecticut

Fewer than 3 recruiting trials found.

All Head and Neck Cancers - Salivary Gland trials nationally

Cities in Connecticut

Recruiting trials in Connecticut

• VMD-928 Monotherapy and in Combination With Pembrolizumab to Treat TrkA Overexpression Driven Solid Tumors or Lymphoma
  NCT03556228 · Phase: Phase 1, Phase 2 · Ages: 18 Years to 80 Years · Sex: All (male and female) · Connecticut: Hartford